Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

1,2,4,-triazin-3,5-dione compounds suitable for treating disorders that respond to modulation of the dopamine D3 receptor

US Patent 8492540 · Granted Jul 23, 2013

Estimated economic value: $58,743,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Targeted drug rescue with novel compositions, combinations, and methods thereof2022
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2022
Compositions and methods thereof2021
Organic reactions carried out in aqueous solution in the presence of a hydroxyal2020
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Fused heterocyclic compounds as S1P modulators2020
Inhibitor compounds of phosphodiesterase type 10A2019
Inhibitor compounds of phosphodiesterase type 10A2019
Fused (hetero)cyclic compounds as S1P modulators2019
Fused (hetero)cyclic compounds as S1P modulators2019
Quinoline compounds suitable for treating disorders that respond to the modulati2018